Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

2.240

-0.130 (-5.49%)

At close: Mar 24, 2026, 4:00 PM EDT

2.316

+0.076 (3.40%)

After-hours: Mar 24, 2026, 7:23 PM EDT

Century Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	61.85	58.44	47.32	84.27	56.45
Short-Term Investments	55.26	130.85	125.41	231.23	166.43
Cash & Short-Term Investments	117.11	189.29	172.74	315.5	222.88
Cash Growth	-38.13%	9.58%	-45.25%	41.56%	194.22%
Other Current Assets	3.66	4.73	4.26	4.22	5.28
Total Current Assets	120.77	194.02	176.99	319.72	228.15
Net Property, Plant & Equipment	66.17	90.85	92.08	111.73	69.82
Other Intangible Assets	34.2	35.21	-	-	-
Long-Term Investments	-	30.82	89.1	51.85	135.91
Other Long-Term Assets	-	2.32	2.52	3.24	3.49
Total Assets	223.7	353.22	360.69	486.54	437.38
Accounts Payable	4.77	3.98	2.74	5.45	7.6
Accrued Expenses	11.7	16.6	10.15	9.84	6.04
Current Portion of Long-Term Debt	-	-	-	6.5	1.04
Unearned Revenue	-	109.1	4.37	7.15	0
Other Current Liabilities	3.76	0.08	0.58	0.87	0.98
Total Current Liabilities	20.23	129.76	17.85	29.82	15.66
Long-Term Debt	-	-	-	3.74	8.9
Long-Term Leases	40.24	48.96	46.66	38.7	14.56
Other Long-Term Liabilities	4.3	4.37	111.44	111.55	2.02
Total Long-Term Liabilities	44.54	53.33	158.1	153.99	25.48
Total Liabilities	64.77	191.85	175.94	183.81	41.14
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	950.81	943.38	840.41	824.29	785.05
Accumulated Other Comprehensive Income	0.03	0.35	0.11	-2.46	-0.65
Retained Earnings	-791.92	-782.39	-655.77	-519.1	-388.17
Shareholders' Equity	158.94	161.36	184.75	302.74	396.24
Total Liabilities & Equity	223.7	353.22	360.69	486.54	437.38
Total Debt	40.24	48.96	46.66	48.94	24.5
Net Cash (Debt)	76.87	140.33	126.08	266.56	198.38
Net Cash Growth	-45.22%	11.30%	-52.70%	34.37%	264.41%
Net Cash Per Share	0.89	1.78	2.13	4.62	6.12
Book Value	158.94	161.36	184.75	302.74	396.24
Book Value Per Share	1.84	2.05	3.11	5.24	12.23
Tangible Book Value	124.74	126.16	184.75	302.74	396.24
Tangible Book Value Per Share	1.44	1.60	3.11	5.24	12.23

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q